SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-106813
Filing Date
2016-06-03
Accepted
2016-06-03 17:02:35
Documents
2
Period of Report
2016-06-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v441732_4.html 4  
1 OWNERSHIP DOCUMENT v441732_4.xml 4 3949
2 POWER OF ATTORNEY v441732_ex24.htm EX-24 5998
  Complete submission text file 0001144204-16-106813.txt   11461
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Issuer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IDG VC MANAGEMENT LTD. UNIT 1509, THE CENTER, 99 QUEEN'S RD CENTRAL K3 -
Business Address
Zhou Quan (Reporting) CIK: 0001491503 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20713 | Film No.: 161696519